Eli Lilly and Company
Cyclobutyl-imidazolidinone compounds
Last updated:
Abstract:
The present invention provides a compound of Formula I ##STR00001## wherein Q is selected from the group consisting of --CH(CH.sub.3).sub.2 and ##STR00002## R is selected from the group consisting of ##STR00003## or a pharmaceutically acceptable salt thereof; compositions, methods to treat liver disease and NASH.
Status:
Grant
Type:
Utility
Filling date:
6 Sep 2018
Issue date:
6 Aug 2019